Use and Outcomes of Triple Therapy Among Older Patients With Acute Myocardial Infarction and Atrial Fibrillation
Year: 2015
Type: article
Study design: Observational Study
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Funders: American Heart Association, Eli Lilly and Company, AstraZeneca, GlaxoSmithKline, Merck, Sanofi, American College of Cardiology Foundation, Gilead Sciences, Boehringer Ingelheim, Boston VA Research Institute, Society of Hospital Medicine, Regado Biosciences, Agency for Healthcare Research and Quality, Genentech, Duke Clinical Research Institute, Janssen Pharmaceuticals
OpenAlex ID: W1090493624
